Literature DB >> 24312828

Thermoanalytical investigation of terazosin hydrochloride.

Ali Kamal Attia1, Mona Mohamed Abdel-Moety.   

Abstract

PURPOSE: Thermal analysis (TGA, DTG and DTA) and differential scanning calorimetry (DSC) have been used to study the thermal behavior of terazosin hydrochloride (TER).
METHODS: Thermogravimetric analysis (TGA/DTG), differential thermal analysis (DTA) and differential scanning calorimetry (DSC) were used to determine the thermal behavior and purity of the used drug. Thermodynamic parameters such as activation energy (E*), enthalpy (∆H*), entropy (∆S*) and Gibbs free energy change of the decomposition (∆G*) were calculated using different kinetic models.
RESULTS: The purity of the used drug was determined by differential scanning calorimetry (99.97%) and specialized official method (99.85%) indicating to satisfactory values of the degree of purity. Thermal analysis technique gave satisfactory results to obtain quality control parameters such as melting point (273 ºC), water content (7.49%) and ash content (zero) in comparison to what were obtained using official method: (272 ºC), (8.0%) and (0.02%) for melting point, water content and ash content, respectively.
CONCLUSION: Thermal analysis justifies its application in quality control of pharmaceutical compounds due to its simplicity, sensitivity and low operational costs. DSC data indicated that the degree of purity of terazosin hydrochloride is similar to that found by official method.

Entities:  

Keywords:  Differential scanning calorimetry; Purity; Terazosin hydrochloride; Thermal analysis

Year:  2013        PMID: 24312828      PMCID: PMC3846028          DOI: 10.5681/apb.2013.025

Source DB:  PubMed          Journal:  Adv Pharm Bull        ISSN: 2228-5881


  11 in total

1.  Validated specific HPLC methods for determination of prazosin, terazosin and doxazosin in the presence of degradation products formed under ICH-recommended stress conditions.

Authors:  Monika Bakshi; Tina Ojha; Saranjit Singh
Journal:  J Pharm Biomed Anal       Date:  2004-01-27       Impact factor: 3.935

2.  Applications of thermal analysis in the pharmaceutical industry.

Authors:  D Giron
Journal:  J Pharm Biomed Anal       Date:  1986       Impact factor: 3.935

3.  Determination of terazosin by cloud point extraction-fluorimetric combined methodology.

Authors:  Chien Chun Wang; Marta O Luconi; Adriana N Masi; Liliana Fernández
Journal:  Talanta       Date:  2007-02-16       Impact factor: 6.057

4.  The use of differential scanning calorimetry for the purity verification of pharmaceutical reference standards.

Authors:  S Mathkar; S Kumar; A Bystol; K Olawoore; D Min; R Markovich; A Rustum
Journal:  J Pharm Biomed Anal       Date:  2008-12-30       Impact factor: 3.935

Review 5.  Rationale for the use of alpha-blockers in the treatment of benign prostatic hyperplasia (BPH).

Authors:  K Kawabe; N Moriyama; S Yamada; N Taniguchi
Journal:  Int J Urol       Date:  1994-09       Impact factor: 3.369

6.  Improved high-performance liquid chromatographic analysis of terazosin in human plasma.

Authors:  P Y Cheah; K H Yuen; M L Liong
Journal:  J Chromatogr B Biomed Sci Appl       Date:  2000-08-18

7.  alpha-Blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it.

Authors:  C Rossi; B B Kortmann; G S Sonke; D L Floratos; L A Kiemeney; H Wijkstra; J J de la ROSETTE
Journal:  J Urol       Date:  2001-01       Impact factor: 7.450

8.  Effect of surfactants on the voltammetric response and determination of an antihypertensive drug.

Authors:  Nada F Atta; Soher A Darwish; Sayed E Khalil; A Galal
Journal:  Talanta       Date:  2007-02-01       Impact factor: 6.057

9.  Binding characteristics of naftopidil and alpha 1-adrenoceptor antagonists to prostatic alpha-adrenoceptors in benign prostatic hypertrophy.

Authors:  S Yamada; M Suzuki; Y Kato; R Kimura; R Mori; K Matsumoto; M Maruyama; K Kawabe
Journal:  Life Sci       Date:  1992       Impact factor: 5.037

10.  Thermal analysis applied to verapamil hydrochloride characterization in pharmaceutical formulations.

Authors:  Maria Irene Yoshida; Elionai Cassiana Lima Gomes; Cristina Duarte Vianna Soares; Alexandre Frinhani Cunha; Marcelo Antonio Oliveira
Journal:  Molecules       Date:  2010-04-08       Impact factor: 4.411

View more
  2 in total

1.  Thermal analysis study of antihypertensive drugs telmisartan and cilazapril.

Authors:  Refaat Ahmed Saber; Ali Kamal Attia; Waheed Mohamed Salem
Journal:  Adv Pharm Bull       Date:  2014-02-07

2.  Thermal Analysis Investigation of Dapoxetine and Vardenafil Hydrochlorides using Molecular Orbital Calculations.

Authors:  Ali Kamal Attia; Eglal R Souaya; Ethar A Soliman
Journal:  Adv Pharm Bull       Date:  2015-11-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.